Dual PI3K/mTOR inhibitors: Does p53 modulate response?

Oleksandr Ekshyyan, Arunkumar Anandharaj, Cherie Ann O. Nathan

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Head and neck squamous cell carcinomas have multiple genetic alterations that can influence clinical response to treatment. It is important to evaluate how distinct alterations affect response to targeted agents to identify a subset of patients who can benefit from therapy, improving survival and decreasing toxicity.

Original languageEnglish (US)
Pages (from-to)3719-3721
Number of pages3
JournalClinical Cancer Research
Issue number14
StatePublished - Jul 15 2013
Externally publishedYes


Dive into the research topics of 'Dual PI3K/mTOR inhibitors: Does p53 modulate response?'. Together they form a unique fingerprint.

Cite this